C12Y 304/21005
Thrombin
Official title: Thrombin (3.4.21.5)
C12Y304/21005 (Thrombin) appears on 329 US grants and 387 published applications in this corpus.
Search patents in C12Y- Granted patents
- 329
- Published applications
- 387
- Assignees
- 210
- Inventors
- 707
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 5 | 0 |
| 1982 | 2 | 0 |
| 1983 | 3 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 4 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 4 | 0 |
| 1991 | 1 | 0 |
| 1992 | 4 | 0 |
| 1993 | 3 | 0 |
| 1994 | 3 | 0 |
| 1995 | 6 | 0 |
| 1996 | 6 | 0 |
| 1997 | 6 | 0 |
| 1998 | 14 | 0 |
| 1999 | 9 | 0 |
| 2000 | 13 | 0 |
| 2001 | 9 | 0 |
| 2002 | 3 | 7 |
| 2003 | 6 | 7 |
| 2004 | 4 | 10 |
| 2005 | 2 | 8 |
| 2006 | 4 | 10 |
| 2007 | 4 | 7 |
| 2008 | 5 | 19 |
| 2009 | 2 | 11 |
| 2010 | 11 | 9 |
| 2011 | 7 | 12 |
| 2012 | 7 | 14 |
| 2013 | 5 | 14 |
| 2014 | 10 | 18 |
| 2015 | 17 | 33 |
| 2016 | 15 | 41 |
| 2017 | 18 | 32 |
| 2018 | 20 | 22 |
| 2019 | 19 | 26 |
| 2020 | 14 | 17 |
| 2021 | 16 | 15 |
| 2022 | 11 | 15 |
| 2023 | 4 | 11 |
| 2024 | 13 | 13 |
| 2025 | 7 | 10 |
| 2026 | 4 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Gla domains as therapeutic agents14 Jul 2026US 12,678,481 B2Gladiator Biosciences, Inc.
- Cell preparation for extemporaneous use, useful for healing and rejuvenation in vivo5 May 2026US 12,616,720 B2RegenLab USA LLC
- Process, tube and device for the preparation of wound healant composition27 Jan 2026US 12,533,398 B2RegenLab USA LLC
- Gla domains as targeting agents20 Jan 2026US 12,527,836 B2Gladiator Biosciences, Inc.
- Malleable controlled release local anesthetic with hemostatic composition7 Oct 2025US 12,433,879 B2Rilento Pharma, LLC
- Powder composition comprising a haemostatic agent24 Sep 2026US 2026/0284157 A1Centre National De La Recherche Scientifique
- Freeze-dried plasma (fdp) for well-balanced coagulation and fibrinolysis, method of preparation and use thereof9 Jul 2026US 2026/0191903 A1Army Medical University, People's Liberation Army, Prc
- Treatment of hemophilia a with fitusiran2 Jul 2026US 2026/0185097 A1Genzyme Corporation
- Compositions and methods for wound healing7 May 2026US 2026/0124243 A1Mayo Foundation for Medical Education and Research
- Malleable controlled release local anesthetic with hemostatic composition29 Jan 2026US 2026/0027098 A1Rilento Pharma, LLC
Most cited
By later US patents
- Hemostatic agent270US 4,655,211 AUnitika Ltd. · 1987
- Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins198US 9,303,079 B2Moderna Therapeutics, Inc. · 2016
- Aptamers specific for biomolecules and methods of making191US 5,756,291 AGilead Sciences, Inc. · 1998
- Method for preparing thrombin for use in a biological glue187US 6,472,162 B1ThermoGenesis Corp. · 2002
- Oil-body proteins as carriers of high-value peptides in plants136US 5,650,554 ASemBioSys Genetics Inc. · 1997